FDA Inspection
Hamilton Medical CenterHamilton Medical Center – FDA Inspection, Jan 14, 2020
Record Details
This FDA Inspection record concerns Hamilton Medical Center, with an inspection on January 14, 2020, issued by the Center for Biologics Evaluation and Research, covering biologics.
- Company
- Hamilton Medical Center
- Inspection Date
- January 14, 2020
- Product Type
- Biologics
View Company Profile
ID · e86a4bae-5097-495c-843e-50c248e550f6
Inspection Facts
No Action Indicated (NAI)
No objectionable conditions or practices were found during the inspection.
- Inspection number
- 1122170
- FDA center
- Biologics
- Project area
- Human Cellular, Tissue, and Gene Therapies
Other FDA inspections of Hamilton Medical Center
7| Date | Classification | Office | Project area |
|---|---|---|---|
| December 20, 2024 | Not classified | Atlanta District Office | |
| February 15, 2018 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| April 13, 2016 | NAI | Center for Biologics Evaluation and Research | Human Cellular, Tissue, and Gene Therapies |
| September 23, 2014 | NAI | Center for Biologics Evaluation and Research | Human Cellular, Tissue, and Gene Therapies |
| July 10, 2012 | NAI | Center for Biologics Evaluation and Research | Human Cellular, Tissue, and Gene Therapies |
Other documents for Hamilton Medical Center
- FDA Inspection 1258970 - 2024-12-20
- FDA Inspection 1042192 - 2018-02-15
- FDA Inspection 966438 - 2016-04-13
- FDA Inspection 897027 - 2014-09-23
- FDA Inspection 790744 - 2012-07-10
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.